The FLT3 gene is the most frequently altered gene in acute myeloid leukemia (AML) with mutations occurring in up to 30% of patients, where higher FLT3 expression has been associated with poor overall survival (OS) [9,10]. This evidence concerns the gene FLT3 and acute myeloid leukemia.